Study Stopped
PI leaving institution, data collected is insufficient for analysis
Promoting Activity After COPD Exacerbations, Aim 2
PACE2
2 other identifiers
interventional
7
1 country
1
Brief Summary
This randomized controlled pilot study involving patients with chronic obstructive pulmonary disease (COPD) recently discharged from the hospital will evaluate the feasibility and efficacy of a home-based mobile-health supported physical activity promotion program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Mar 2019
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2019
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedStudy Start
First participant enrolled
March 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 8, 2022
CompletedJanuary 20, 2025
March 1, 2023
3.1 years
January 2, 2019
January 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in mean daily step counts
change in mean daily step counts (averaged over 1 week) over time using repeated measures over the 12 weeks of the study.
12 weeks
Secondary Outcomes (4)
Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Depression
12 weeks
PROMIS Emotional Distress - Anxiety
12 weeks
PROMIS Fatigue
12 weeks
PROMIS Physical function
12 weeks
Study Arms (2)
PACE2 Intervention
EXPERIMENTALAll participants will receive usual healthcare as per their treating medical team and carry a pedometer for recording of physical activity. In addition, participants randomized to the PACE2 intervention will receive written educational materials regarding physical activity, telephone-based coaching to integrate physical activity in daily life activities and address barriers to attending pulmonary rehabilitation.
Enhanced Usual Care
NO INTERVENTIONAll participants will receive usual healthcare as per their treating medical team and carry a pedometer for recording of physical activity.
Interventions
Written educational materials regarding physical activity, telephone-based coaching to integrate physical activity in daily life activities and address barriers to attending pulmonary rehabilitation.
Eligibility Criteria
You may qualify if:
- Age 18 years or older;
- Physician diagnosis of COPD;
- Hospitalized as an inpatient, 23-hour observation, or clinical decision unit
- Admitting respiratory conditions sensitive to the Centers for Medicare and Medicaid Services Hospital Readmission Reduction Program as listed below:
- COPD exacerbation
- Asthma/COPD overlap
- Decompensated heart failure
- Pneumonia
- Chronic Airway Disease
You may not qualify if:
- Physical inability to participate in a walking program;
- Oxygen saturation \<90% by pulse oximetry refractory to supplemental oxygen, or in a patient unable or unwilling to use supplemental oxygen;
- Fall in the previous 6 months;
- Resting electrocardiogram (ECG) with new ST changes or tachyarrhythmia;
- Planned discharge home to hospice or to long term care facility/skilled nursing facility;
- Life expectancy \<3 months;
- Medical contraindication to participating in a physical activity promotion program as determined by the inpatient treating clinician;
- Unable to communicate in English;
- Unable or declines to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jerry Krishnan, MD
University of Illinois at Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Allocation sequence will be concealed
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 2, 2019
First Posted
January 4, 2019
Study Start
March 18, 2019
Primary Completion
April 8, 2022
Study Completion
April 8, 2022
Last Updated
January 20, 2025
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share